文献速递传染病防控与疫情报告免疫规划

日本一家高疫苗接种率医疗中心Delta变异株SARS-CoV-2感染增加

Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan.
PubMed 文献 · Vaccine · 2022-04-12

日本东京一家医疗中心对3911名医护人员进行回顾性队列研究,疫苗接种率84.1%。Delta变异株流行期间,完全接种的3289名医护人员中报告16例突破性感染,未接种的574名中报告11例,8月病例率分别为4.0/1000和19.2/1000,所有突破性病例均为Delta变异株。

要点

  • 研究期间完全接种者中突破性感染16例,未接种者11例,突破性病例均为Delta变异株。
  • 8月病例率:完全接种组4.0/1000 vs 未接种组19.2/1000。
  • 研究确认BNT162b2对Delta有稳健疫苗效果,但突破性感染增加提示高风险环境仍需持续感染控制措施。

核心结论

  • 研究确认BNT162b2疫苗对Delta变异株具有稳健的疫苗效果,但突破性感染增加提示即使达到高疫苗接种覆盖率,高风险环境仍需持续感染控制措施。

研究设计与样本

  • 回顾性队列研究,纳入日本东京一家医疗中心的3911名医护人员,疫苗接种率84.1%。

主要发现

  • 2021年6月前,在包括普遍佩戴口罩的严格感染控制方案下,接种和未接种医护人员中仅发现少量病例。
  • 2021年7月和8月Delta在东京传播期间,3289名完全接种医护人员中报告16例,574名未接种医护人员中报告11例。
  • 8月病例率:完全接种组4.0/1000 vs 未接种组19.2/1000。
  • 所有突破性病例均确认为Delta变异株。

关键数值与推荐

  • 8月病例率:完全接种组4.0/1000 vs 未接种组19.2/1000。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Delta variant has dominated SARS-CoV-2 infections in Tokyo, Japan from June 2021 to date. We conducted a retrospective cohort study to assess BNT162b2 vaccine effectiveness during the surge in Delta among 3,911 healthcare workers (HCWs) at a medical center of Tokyo with a high vaccination rate of 84.1%. With strict infection control protocols including universal masking, only a small number of cases among vaccinated and unvaccinated HCWs were identified before June. As Delta spread in Tokyo, 16 cases among 3,289 fully vaccinated HCWs and 11 cases among 574 unvaccinated HCWs were reported in July and August (case rate in August: 4.0 vs. 19.2 per 1,000). All breakthrough cases were confirmed as Delta. While our study confirms a robust vaccine effectiveness of BNT162b2 vaccine against Delta, rising breakthrough cases suggest that continued infection control measures are warranted in higher risk environments, even when high rates of vaccination coverage are achieved.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yan Y, Naito T, Tabe Y, et al. Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan. Vaccine. 2022. PMID: 35465978. doi:10.1016/j.vaccine.2022.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。